Author(s): Eichler HG, Thomson A, Eichler I, Schneeweiss S
The increasing availability of individual-level data from clinical trials could allow the relative efficacy of new drugs to be assessed in a robust, cost-effective and timely way.
Referred From: http://www.nature.com/articles/nrd4664
